You have no items in your shopping cart.
On Promotion 
Tested Applications
Reactivity
Predicted Reactivity
Conjugation
Unconjugated 337Biotin 44HRP 32FITC 30PE 29APC 26Cy3 14AP 12iFluor647 9IRDye800 8APC/Cy7 6PE/Cy5.5 6PE/Cy7 6APC/Cy5.5 5BF350 5BF405 5BF488 5BF555 5BF594 5BF647 5BF680 5BF700 5BF750 5Cy5 5Cy5.5 5Cy7 5PE/Cy5 5Pacific Blue 5PerCP 5PerCP/Cy5.5 5PerCP/Cy7 5RBITC 5AE 1IRDye800CW 1PE/Texas Red 1RPE 1SureLight 488 1
Biologically Active
Featured Product
Human IL-4 [orb3002435]SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 95% as determined by SEC-HPLC.(QC verified)
Predicted: 16 KDa. Observed: 17-22&15 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg- Human IL-4 [orb3002443]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 95% as determined by SEC-HPLC. (Regularly tested)
Predicted: 15.1 KDa. Observed: 13-14 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Mouse IL-4 [orb3002465]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 95% as determined by SEC-HPLC. (Regularly tested)
Predicted: 13.4 KDa. Observed: 14 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Mouse IL-4 [orb3002476]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 14.6 KDa. Observed: 15-22 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human IL-4 [orb3002477]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 14.97 KDa. Observed: 18 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg 
IL-4 (Interleukin-4), Mouse Antibody [orb608016]ELISA, FC, IF
Mouse
Rat
Monoclonal
Unconjugated
100 μg (without BSA and Azide), 100 μg, 20 μg- Item 1 of 1IL-4 Antibody [orb214098]Featured
IF, IHC, WB
Human, Monkey, Rat
Rabbit
Polyclonal
Unconjugated
30 μl, 100 μl, 200 μl, 50 μl
